|
Urology / Nephrology News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
New Surgery Without Incisions Shows Promise For Prostate Cancer Treatment
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next step in the evolution of minimally invasive surgery. Removing the prostate is a common treatment for patients with prostate cancer, which affects one in six men in the U.S...
-
Dense Bones Linked To Raised Risk For Prostate Cancer
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health...
-
Millions Of Americans In Early Stages Of Kidney Disease Need Stroke Monitoring
Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) - a major risk factor for stroke - according to new research by investigators at Wake Forest University Baptist Medical Center...
-
News From The American Journal Of Pathology
Transforming Growth Factor-βa (TGF-β1) Contributes to Kidney Disease Dr...
-
Antares Pharma Announces Positive Top Line Results From Its Pivotal Phase 3 Study Of Anturol Gel For The Treatment Of Overactive Bladder
Antares Pharma, Inc. (NYSE Amex:AIS) announced positive results from its Phase 3 study of AnturolTM Gel in patients with overactive bladder (OAB). The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied (56 mg daily or 84 mg daily, p=0.028 and 0.033 respectively)...
-
Genzyme Encouraged By CMS Decision To Delay Oral Drug Inclusion In Dialysis Patient Benefit
Genzyme Corp. (NASDAQ: GENZ) said it welcomed the Centers for Medicare and Medicaid Services' (CMS) decision not to include oral medications without IV equivalents in Medicare's End Stage Renal Disease (ESRD) patient benefit. According to the final rule, these medications, including Genzyme's Renvela® (sevelamer carbonate), will not be included in the bundle until January 1, 2014...
-
Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States...
-
Medicare To Bundle Payments For End-Stage Renal Care, Reward Quality
Modern Healthcare: Medicare payment for end-stage renal disease care may soon be tied to performance and quality measures if a new proposed rule issued by the Centers for Medicare and Medicaid Services is finalized...
-
Don't Blame The PSA Test For The 'Overtreatment' Of Prostate Cancer
A new report published in the July 26 issue of Archives of Internal Medicine claims many men who are diagnosed with prostate cancer undergo aggressive therapy, even when they have low PSA scores and low-risk disease, saying "these results underscore the fact that PSA level, the current biomarker, is not a sufficient basis for treatment decisions...
-
63% Of Women Report Sexual Problems With Orgasm Proving Biggest Issue In Teens And 20s
Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54...
-
NYU Langone Begins Clinical Trial Offering Vascular-Targeted Photodynamic Therapy To Patients With Localized Prostate Cancer
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells...
-
AMD Appoints BK Medical As Agent For Prostate HistoScanning™ In The UK
Advanced Medical Diagnostics SA (AMD), a privately held company committed to providing innovative computer-aided solutions (HistoScanning™) that can improve the diagnostic interpretation of ultrasound scans, announced that it has appointed BK Medical UK Ltd as sole agent for Prostate HistoScanning™ in the UK...
-
Proposed Lowering Of PSA Threshold For Biopsy Could Result In Increased Overdiagnosis And Overtreatment Of Prostate Cancer, Study
New research from the US suggests that most American men diagnosed with prostate cancer receive aggressive treatment, even if their prostate-specific antigen (PSA) level is below the current recommended 4...
-
CMS Announces New Prospective Payment System For End-Stage Renal Disease Facilities
The Centers for Medicare & Medicaid Services (CMS) issued a final rule that will change how Medicare pays for dialysis services for Medicare beneficiaries who have end-stage renal disease (ESRD)...
-
First Nations People On Peritoneal Dialysis At Greater Risk Of Infection And Death
First Nations people in Canada on peritoneal dialysis are at increased risk of peritonitis and death, irrespective of whether they live in a rural or urban location, found a study published in CMAJ (Canadian Medical Association Journal)...
|